VERU VERU INC.
P/E
--
Forward P/E
117.65
Price/Sales
3.11
Beta
-1.196
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Veru Announces Clinical Supply Agreement with Novo Nordisk for Phase 2b Obesity Trial
Veru Inc. has entered into a clinical supply agreement with Novo Nordisk A/S to support its Phase 2b PLATEAU clinical study. The study will evaluate the...
Veru Landed a Novo Nordisk Deal and Doubled in a Day — But Can a $60 Million Biotech Sustain the Hype?
Shares of Veru Inc. (VERU) are pulling back 10.4% to $3.79 this morning after an explosive rally that saw the stock surge as much as 161% intraday on...
🔴 Veru Inc is trading 10.4% down today on profit-taking after yesterday's 88% surge from a Novo Nordisk deal
Veru Inc is trading 10.4% down at $3.79 as the stock undergoes consolidation and profit-taking following yesterday's massive 88% rally. • The prior-day surge...
Veru stock surges on Novo Nordisk deal for Wegovy obesity trial
Veru Inc. entered a clinical supply agreement with Novo Nordisk for the Phase 2b PLATEAU trial. Novo Nordisk will provide its weight-loss drug Wegovy...